Literature DB >> 17698236

Assessing the expression of chicken anemia virus proteins in plants.

Cristiano Lacorte1, Hendrikus Lohuis, Rob Goldbach, Marcel Prins.   

Abstract

Chicken anemia virus (CAV) is an important pathogen of chicken worldwide, causing severe anemia and immunodeficiency. Its small single-stranded DNA genome (2.3kb) encodes three proteins: VP1, the only structural protein, VP2, a protein phosphatase, and VP3, also known as apoptin, which induces apoptosis. In this study, CAV proteins were expressed in plants as an alternative for recombinant protein production in animal cells. Additionally, the effect of VP3 expression was tested to evaluate possible involvement in programmed cell death in plants. The CAV genes were cloned in binary vectors with the Green fluorescent protein (GFP) as N terminal fusion, and into a Potato virus X (PVX) and Tobacco Mosaic Virus (TMV)-based vectors. Nicotiana benthamiana plants were inoculated with Agrobacterium tumefaciens containing the binary vector constructs or the PVX and TMV constructs. Upon transient expression GFP:VP1 and GFP:VP2 were observed throughout the nucleoplasm, whereas VP3 formed compact aggregates within the nucleus, indicating functional nuclear localization signals in all three proteins. An intense fluorescence was observed for VP2 and VP3 fusions, whereas GFP:VP1 fluorescence remained faint and was only detected in a limited number of cells. Co-expression of GFP:VP1 and VP2 had a marked alteration on the distribution of GFP:VP1, forming large VP1 aggregates throughout the nucleus, indicating an interaction of the two CAV proteins. No visible alteration on GFP pattern was detected upon co-expression of GFP:VP1 and VP3, or with GFP:VP2 and VP3. Plants infected with PVX or TMV-based vectors expressing VP3 displayed strong necrosis and wilting, however, a direct association with VP3 expression and programmed cell death in plants, could not be established. Overall, our results show that all CAV proteins can be expressed in plant cells, though expression level of VP1 needs to be further optimized before testing its potential as (edible) subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698236     DOI: 10.1016/j.virusres.2007.06.020

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

1.  Efficient production of an engineered apoptin from chicken anemia virus in a recombinant E. coli for tumor therapeutic applications.

Authors:  Meng-Shiou Lee; Fang-Chun Sun; Chi-Hung Huang; Yi-Yang Lien; Shin-Huei Feng; Guan-Hua Lai; Meng-Shiunn Lee; Jung Chao; Hsi-Jien Chen; Jason T C Tzen; Hao-Yuan Cheng
Journal:  BMC Biotechnol       Date:  2012-06-06       Impact factor: 2.563

2.  Transient expression of hemagglutinin antigen from low pathogenic avian influenza A (H7N7) in Nicotiana benthamiana.

Authors:  Selvaraju Kanagarajan; Conny Tolf; Anneli Lundgren; Jonas Waldenström; Peter E Brodelius
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

3.  An induced hypersensitive-like response limits expression of foreign peptides via a recombinant TMV-based vector in a susceptible tobacco.

Authors:  Mangmang Li; Ping Li; Rentao Song; Zhengkai Xu
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

4.  High yield expression in a recombinant E. coli of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development.

Authors:  Meng-Shiou Lee; You-Cheng Hseu; Guan-Hua Lai; Wen-Te Chang; Hsi-Jien Chen; Chi-Hung Huang; Meng-Shiunn Lee; Min-Ying Wang; Jung-Yie Kao; Bang-Jau You; Wen- Hsin Lin; Yi-Yang Lien; Ming-Kuem Lin
Journal:  Microb Cell Fact       Date:  2011-07-23       Impact factor: 5.328

5.  Identification of the NLS and NES motifs of VP2 from chicken anemia virus and the interaction of VP2 with mini-chromosome maintenance protein 3.

Authors:  Jai-Hong Cheng; Shyang-Chwen Sheu; Yi-Yang Lien; Meng-Shiunn Lee; His-Jien Chen; Wen-Hong Su; Meng-Shiou Lee
Journal:  BMC Vet Res       Date:  2012-02-07       Impact factor: 2.741

6.  Development and characterization of a potential diagnostic monoclonal antibody against capsid protein VP1 of the chicken anemia virus.

Authors:  Yi-Yang Lien; Chi-Hung Huang; Fang-Chun Sun; Shyang-Chwen Sheu; Tsung-Chi Lu; Meng-Shiunn Lee; Shu-Chin Hsueh; Hsi-Jien Chen; Meng-Shiou Lee
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

7.  Improving the potency of DNA vaccine against chicken anemia virus (CAV) by fusing VP1 protein of CAV to Marek's Disease Virus (MDV) type-1 VP22 protein.

Authors:  Hassan Moeini; Abdul Rahman Omar; Raha Abdul Rahim; Khatijah Yusoff
Journal:  Virol J       Date:  2011-03-14       Impact factor: 4.099

Review 8.  Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?

Authors:  Christopher Concha; Raúl Cañas; Johan Macuer; María José Torres; Andrés A Herrada; Fabiola Jamett; Cristian Ibáñez
Journal:  Vaccines (Basel)       Date:  2017-05-30

9.  Expression and characterization of highly antigenic domains of chicken anemia virus viral VP2 and VP3 subunit proteins in a recombinant E. coli for sero-diagnostic applications.

Authors:  Guan-Hua Lai; Ming-Kuem Lin; Yi-Yang Lien; Jiun-Hau Fu; Hsi-Jien Chen; Chi-Hung Huang; Jason T C Tzen; Meng-Shiou Lee
Journal:  BMC Vet Res       Date:  2013-08-13       Impact factor: 2.741

10.  Characterization of the DNA binding activity of structural protein VP1 from chicken anaemia virus.

Authors:  Guan-Hua Lai; Ming-Kuem Lin; Yi-Yang Lien; Jai-Hong Cheng; Fang-Chun Sun; Meng-Shiunn Lee; Hsi-Jien Chen; Meng-Shiou Lee
Journal:  BMC Vet Res       Date:  2018-05-04       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.